Document Detail


Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.
MedLine Citation:
PMID:  19752344     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To investigate the prevalence of arthralgia in breast cancer patients taking aromatase inhibitors (AIs) and perform a detailed rheumatologic assessment including autoimmune serology, musculoskeletal sonography, and electromyography (EMG) in these patients. PATIENTS AND METHODS: Postmenopausal patients with stage I to III breast cancer who were taking adjuvant AIs were enrolled (n = 92). Patients who were not receiving hormone treatment were included as a control group (n = 28). Musculoskeletal sonography and EMG were applied to the patients and the controls along with markers of autoimmunity. RESULTS: Thirty patients (32.6%) reported to have AI-related new-onset or worsening arthralgia. The most commonly affected joints were knee (70%), wrist (70%), and small joints of the hand (63%). Patients taking AIs had increased tendon thicknesses compared with those who never received AIs (P < .001). Patients with AI-related arthralgia had higher rates of effusion in hand joints/tendons than those without arthralgia (P = .033). More patients with AI-related arthralgia had EMG findings consistent with carpal tunnel syndrome (CTS) than those without arthralgia (P = .024). No significant difference was observed in erythrocyte sedimentation rates, C-reactive protein, antinuclear antibody, antidouble stranded DNA antibody, rheumatoid factor, or anticyclic citrullinated peptide levels between patients and controls or between those with and without arthralgia. CONCLUSION: Patients with AI-related arthralgia often show tenosynovial changes suggesting tenosynovitis, exerting local problems but lacking a systemic inflammatory component. Our finding of increased CTS frequency also supports this hypothesis.
Authors:
Omer Dizdar; Levent Ozçakar; Fevziye Unsal Malas; Hakan Harputluoglu; Nilufer Bulut; Sercan Aksoy; Yavuz Ozisik; Kadri Altundag
Related Documents :
2307374 - Salvage of lisfranc's tarsometatarsal joint by arthrodesis.
9565954 - Frozen shoulder syndrome: diagnostic and treatment strategies in the primary care setting.
4051704 - Anterior cruciate ligament insufficiency treated by combined medial and lateral extra-a...
11380634 - Motor performance and disability in dutch children with haemophilia: a comparison with ...
20561984 - Study of chromosomal region 5p13.1 in crohn's disease, ulcerative colitis, and rheumato...
8685934 - Lipoprotein(a) in patients with acute cerebral ischemia.
Publication Detail:
Type:  Journal Article     Date:  2009-09-14
Journal Detail:
Title:  Journal of clinical oncology : official journal of the American Society of Clinical Oncology     Volume:  27     ISSN:  1527-7755     ISO Abbreviation:  J. Clin. Oncol.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-19     Completed Date:  2009-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309333     Medline TA:  J Clin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4955-60     Citation Subset:  IM    
Affiliation:
Hacettepe University Institute of Oncology, Department of Medical Oncology, Ankara, Turkey. omerdiz@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aromatase Inhibitors / adverse effects*,  therapeutic use
Arthralgia / chemically induced*,  diagnosis*,  epidemiology
Breast Neoplasms / drug therapy*
Electromyography
Female
Humans
Middle Aged
Postmenopause
Prevalence
Prospective Studies
Ultrasonography
Chemical
Reg. No./Substance:
0/Aromatase Inhibitors
Comments/Corrections
Comment In:
J Clin Oncol. 2009 Oct 20;27(30):4932-4   [PMID:  19752332 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in...
Next Document:  ERG expression is an independent prognostic factor and allows refined risk stratification in cytogen...